Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02893501 · ClinicalTrials.gov registry record
Infant Microbiome in Diaper Rash
A clinical trial of Diaper Rash, sponsored by Kimberly-Clark Corporation.
- Completed
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT02893501 is a study of Diaper Rash that has completed, run by Kimberly-Clark Corporation. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02893501, a study of Diaper Rash, has completed, sponsored by Kimberly-Clark Corporation.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate the microbiome composition of infant's (9-12 month) skin experiencing diaper rash in order to determine if the onset and severity of erythema associated with diaper rash is influenced by the type of bacteria colonizing the skin.
Conditions Studied
Study Locations (1)
Nebraska
- Midwest Children's Health Research Institute - Lincoln
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2016-09 |
| Est. Completion | 2017-01-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02893501
The ClinicalTrials.gov registry entry for NCT02893501 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kimberly-Clark Corporation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diaper Rash appearing as the primary indexed condition, and to 0 interventions.
NCT02893501 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.
Frequently Asked Questions
What is clinical trial NCT02893501 about?
NCT02893501 is a clinical study titled "Infant Microbiome in Diaper Rash". The objective of this study is to evaluate the microbiome composition of infant's (9-12 month) skin experiencing diaper rash in order to determine if the onset and severity of erythema associated with diaper rash is influenced by the type of bacteria colonizing the skin.
What is the current status of trial NCT02893501?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2016-09. Estimated completion is 2017-01-04.
What conditions does trial NCT02893501 study?
This clinical trial studies the following conditions: Diaper Rash.
Who is sponsoring clinical trial NCT02893501?
This trial is sponsored by Kimberly-Clark Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02893501 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.